Targeting CD20 in melanoma patients at high risk of disease recurrence.

Molecular Therapy : the Journal of the American Society of Gene Therapy
Alice PincStephan N Wagner

Abstract

Melanomas contain distinct cell subpopulations. Several of these subpopulations, including one expressing CD20, may harbor stem cell-like or tumor-initiating characteristics. We hypothesized that patients at high risk of disease recurrence could benefit from an adjuvant anti-CD20 therapy. Therefore, we initiated a small pilot trial to study the effect of the anti-CD20 antibody rituximab in a group of melanoma patients with stage IV metastatic disease who had been rendered without evident disease by way of surgery, chemotherapy and/or radiation therapy. The major objective was safety, while secondary objectives were description of recurrence-free intervals (RFI) and overall survival (OS). Nine patients received rituximab at 375 mg/m(2) qw for 4 weeks followed by a maintenance therapy every 8 weeks. Treatment was discontinued after 2 years or with disease recurrence. Treatment was well tolerated. After a median observation of 42 months, the median neither of RFI nor of OS has been reached. Despite therapy that ended after 2 years, six out of nine patients are still alive and five of them are recurrence-free. Though the patient number is too small for definitive conclusions, our data may represent a first example of the potential ...Continue Reading

References

Jul 21, 1988·Nature·O LassilaP Matzinger
Aug 17, 2000·British Journal of Cancer·F LeoU Pastorino
Nov 2, 2001·Nature·T ReyaI L Weissman
Oct 31, 2002·Seminars in Oncology·Emilio BajettaDavid Khayat
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eddy C HsuehDonald L Morton
Sep 24, 2004·Archives of Surgery·Richard EssnerDonald L Morton
Apr 15, 2005·Nature·Tannishtha Reya, Hans Clevers
May 25, 2005·International Journal of Cancer. Journal International Du Cancer·Sangeeta ShahJoseph D Rosenblatt
Oct 19, 2005·Cancer Research·Dong FangMeenhard Herlyn
Mar 28, 2006·Cell·Michael F Clarke, Margaret Fuller
Jan 3, 2007·The Journal of Thoracic and Cardiovascular Surgery·Rebecca P PetersenDavid H Harpole
Feb 27, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Elena MonzaniCaterina A M La Porta
Jul 3, 2007·Cancer Immunology, Immunotherapy : CII·Femke HillenArjan W Griffioen
Jan 19, 2008·Nature·Tobias SchattonMarkus H Frank
Feb 1, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward L KornJohn M Kirkwood
Mar 28, 2008·BMC Cell Biology·David RobertsonClare M Isacke
May 1, 2008·Journal of the National Cancer Institute·Xiaoxian LiJenny C Chang
Jul 2, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adil I DaudDmitry Gabrilovich
Nov 26, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adil I DaudRichard Heller
Dec 5, 2008·Nature·Elsa QuintanaSean J Morrison
Jun 30, 2009·Cancer Immunology, Immunotherapy : CII·Miriam ReuschenbachNicolas Wentzensen
Sep 8, 2009·Nature Medicine·Piyush B GuptaRobert A Weinberg
Sep 10, 2009·Cell·Mark ShackletonSean J Morrison
Oct 3, 2009·Annals of the New York Academy of Sciences·Tobias Schatton, Markus H Frank
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Jan 6, 2010·Cancer Research·Matthew A HeldMarcus W Bosenberg
Jan 7, 2010·The Journal of Clinical Investigation·Natasha Y FrankMarkus H Frank
Feb 9, 2010·Cancer Cell·Pauline AndreuLisa M Coussens
Feb 11, 2010·Cell Stem Cell·Justin Voog, D Leanne Jones
Mar 3, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·David J DiLilloThomas F Tedder
Mar 12, 2010·Nature·Massimo AmmiranteMichael Karin
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Aug 27, 2010·The Journal of Investigative Dermatology·Jim B BoonyaratanakornkitRuby Ghadially
Sep 8, 2010·The New England Journal of Medicine·Keith T FlahertyPaul B Chapman
Oct 22, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Brad H Nelson
Jan 29, 2011·The Journal of Investigative Dermatology·Verena KupasKarin Loser
Feb 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Patrick SchmidtHinrich Abken
Jun 10, 2011·The Journal of Investigative Dermatology·Mizuho Fukunaga-KalabisMeenhard Herlyn

❮ Previous
Next ❯

Citations

Feb 27, 2013·Clinics in Dermatology·Deborah LangChristopher R Shea
Oct 18, 2012·Cancer Letters·Olga Shakhova, Lukas Sommer
Jan 30, 2015·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander Roesch
Aug 6, 2015·Nanomedicine·Vaibhav MundraRam I Mahato
May 15, 2015·Cellular and Molecular Life Sciences : CMLS·Hong QiuGaoliang Ouyang
Jun 10, 2014·International Reviews of Immunology·Leonardo Chicaybam, Martin Hernan Bonamino
Apr 25, 2016·Human Pathology·Kanika GargStephan N Wagner
Dec 8, 2016·Canadian Journal of Physiology and Pharmacology·Christina Valbirk KonradRadhika Nair
Nov 22, 2017·Medical Sciences : Open Access Journal·Ugo TestaElvira Pelosi
Apr 7, 2018·International Journal of Dermatology·Alyson V RidpathBenjamin H Kaffenberger
Mar 9, 2018·Cancer Immunology, Immunotherapy : CII·Julia K WinklerJessica C Hassel
Oct 16, 2013·Laboratory Investigation; a Journal of Technical Methods and Pathology·Nayoung LeeTobias Schatton
May 16, 2019·Cells·Anne LargeotJerome Paggetti
Sep 15, 2019·Nature Communications·Johannes GrissStephan N Wagner
Sep 21, 2017·Nature Communications·Rajasekharan SomasundaramStephan N Wagner
May 1, 2015·Melanoma Management·Vincenzo VillaniSoldano Ferrone
May 17, 2017·Oncoimmunology·Giulia ChiaruttiniSophia N Karagiannis
Nov 1, 2015·Melanoma Management·Rosie Qin, April Ks Salama
Dec 29, 2020·Immunological Reviews·Daniel MichaudYuliya Pylayeva-Gupta
Feb 12, 2021·Frontiers in Immunology·Zena N WillsmoreSophia N Karagiannis
Feb 13, 2021·Cells·Guilhem LalleYenkel Grinberg-Bleyer
Dec 16, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zahra PayandehSaeed Khalil
Aug 14, 2021·Acta Pharmaceutica Sinica. B·Javad MasoumiHamid Reza Mirzaei

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
Patrick SchmidtHinrich Abken
Molecular Therapy : the Journal of the American Society of Gene Therapy
Rajasekharan SomasundaramMeenhard Herlyn
The Journal of Investigative Dermatology
Tobias Schatton, Markus H Frank
© 2022 Meta ULC. All rights reserved